Life Sciences and Pharma IP 2026

Contents

INTRODUCTION Contributed by Daniel Lim, Steven Baldwin and Jin Ooi, Kirkland & Ellis International LLP p.4

NORWAY Law and Practice p.145 Contributed by Wikborg Rein Advokatfirma AS

AUSTRALIA Trends and Developments p.9 Contributed by Maddocks

PHILIPPINES Law and Practice p.157 Contributed by Villaraza & Angangco POLAND Law and Practice p.174 Contributed by A&O Shearman

BRAZIL Law and Practice p.16

Contributed by Licks Attorneys Trends and Developments p.32 Contributed by Licks Attorneys CHINA Law and Practice p.38 Contributed by LeanWill Law Firm Contributed by HOFFMANN EITLE Trends and Developments p.74 Contributed by HOFFMANN EITLE INDIA Trends and Developments p.81 Contributed by Anand and Anand GERMANY Law and Practice p.57

SAUDI ARABIA Law and Practice p.193 Contributed by Mohammed AlDhabaan & Partners Eversheds Sutherland Trends and Developments p.209 Contributed by Mohammed AlDhabaan & Partners Eversheds Sutherland

SINGAPORE Law and Practice p.214 Contributed by Drew & Napier LLC

SOUTH KOREA Law and Practice p.234

Contributed by Bae, Kim & Lee LLC Trends and Developments p.246 Contributed by Bae, Kim & Lee LLC

ISRAEL Law and Practice p.89 Contributed by Gilat, Bareket & Co, Reinhold Cohn Group

USA Law and Practice p.253

Contributed by Gemini Law LLP Trends and Developments p.270 Contributed by Tensegrity Law Group LLP

JAPAN Law and Practice p.108

Contributed by Ohno & Partners Trends and Developments p.119 Contributed by Nagashima Ohno & Tsunematsu

MEXICO Law and Practice p.126 Contributed by Arochi & Lindner

3 CHAMBERS.COM

Powered by